high dose cytarabine

DRUG2 trials

Sponsors

International Extranodal Lymphoma Study Group (IELSG), Asan Medical Center

Conditions

Acute Myeloid LeukemiaLymphoma, B Cell

Phase 2

Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma

CompletedNCT00210314

International Extranodal Lymphoma Study Group (IELSG)Lymphoma, B Cell

Start: 2003-07-31End: 2007-12-31Updated: 2015-03-30

Phase 3

A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML.

Enrolling by invitationNCT03507842

Asan Medical CenterAcute Myeloid Leukemia

Start: 2018-03-01End: 2028-12-31Target: 380Updated: 2025-03-17

Related Papers

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

2009-09-18441 citations